Literature DB >> 30848474

Impaired Spatial Cognition in Adult Rats Treated with Multiple Intracerebroventricular (ICV) Infusions of the Enteric Bacterial Metabolite, Propionic Acid, and Return to Baseline After 1 Week of No Treatment: Contribution to a Rodent Model of ASD.

Jennifer R Mepham1,2, Francis H Boon2,3, Kelly A Foley1,2, Donald P Cain1,2,3, Derrick F MacFabe2,3, Klaus-Peter Ossenkopp4,5,6.   

Abstract

Propionic acid (PPA) is a dietary short chain fatty acid and an enteric bacterial metabolite. Intracerebroventricular (ICV) infusions of PPA in rodents have been shown to produce behavioral changes similar to those seen in autism spectrum disorders (ASD), including perseveration. The effects of ICV infusions of PPA on spatial cognition were examined by giving rats infusions of either PPA (0.26 M, pH 7.4, 4 μl/infusion) or phosphate-buffered saline (PBS, 0.1 M) twice a day for 7 days. The rats were then tested in the Morris water maze (MWM) for acquisition of spatial learning. After a recovery period of 1 week of no treatment, the rats were then tested for reversal of spatial learning in the MWM. PPA-treated rats showed impaired spatial learning in the maze, relative to controls, as demonstrated by increased search latencies, fewer direct and circle swims, and more time spent in the periphery of the maze than PBS controls. After a recovery period of 1 week of no treatment, these animals exhibited normal spatial reversal learning indicating that the behavioral cognitive deficits caused by PPA seem to be reversible.

Entities:  

Keywords:  Animal model; Autism spectrum disorders; Perseveration; Rat; Short chain fatty acid; Spatial cognition

Mesh:

Substances:

Year:  2019        PMID: 30848474     DOI: 10.1007/s12640-019-0002-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  69 in total

1.  Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine.

Authors:  H Hara; S Haga; Y Aoyama; S Kiriyama
Journal:  J Nutr       Date:  1999-05       Impact factor: 4.798

2.  Autism in Northern Finland.

Authors:  M Kielinen; S L Linna; I Moilanen
Journal:  Eur Child Adolesc Psychiatry       Date:  2000-09       Impact factor: 4.785

3.  Effect of chemically induced propionic acidemia on neurobehavioral development of rats.

Authors:  A M Brusque; C F Mello; D N Buchanan; S T Terracciano; M P Rocha; C R Vargas; C M Wannmacher; M Wajner
Journal:  Pharmacol Biochem Behav       Date:  1999-11       Impact factor: 3.533

4.  Gastrointestinal abnormalities in children with autistic disorder.

Authors:  K Horvath; J C Papadimitriou; A Rabsztyn; C Drachenberg; J T Tildon
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

5.  Formation of propionate after short-term ethanol treatment and its interaction with the carnitine pool in rat.

Authors:  V Calabrese; V Rizza
Journal:  Alcohol       Date:  1999-10       Impact factor: 2.405

6.  Propionic acid stimulates superoxide generation in human neutrophils.

Authors:  S Nakao; Y Moriya; S Furuyama; R Niederman; H Sugiya
Journal:  Cell Biol Int       Date:  1998       Impact factor: 3.612

7.  Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism.

Authors:  J L Ingram; S M Peckham; B Tisdale; P M Rodier
Journal:  Neurotoxicol Teratol       Date:  2000 May-Jun       Impact factor: 3.763

8.  Prenatal viral infection causes alterations in nNOS expression in developing mouse brains.

Authors:  S H Fatemi; A E Cuadra; E E El-Fakahany; R W Sidwell; P Thuras
Journal:  Neuroreport       Date:  2000-05-15       Impact factor: 1.837

Review 9.  Autism and gastrointestinal symptoms.

Authors:  Karoly Horvath; Jay A Perman
Journal:  Curr Gastroenterol Rep       Date:  2002-06

10.  Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism.

Authors:  Naoko Narita; Michiko Kato; Mami Tazoe; Kaoru Miyazaki; Masaaki Narita; Nobuo Okado
Journal:  Pediatr Res       Date:  2002-10       Impact factor: 3.756

View more
  4 in total

1.  PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats.

Authors:  Aarti Sharma; Sonalika Bhalla; Sidharth Mehan
Journal:  Metab Brain Dis       Date:  2022-06-10       Impact factor: 3.655

Review 2.  Propionate and Alzheimer's Disease.

Authors:  Jessica Killingsworth; Darrell Sawmiller; R Douglas Shytle
Journal:  Front Aging Neurosci       Date:  2021-01-11       Impact factor: 5.750

3.  Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer's disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis.

Authors:  Hei-Jen Huang; Jie-Ling Chen; Jian-Fu Liao; Yu-Hsin Chen; Min-Wei Chieu; Ya-Yun Ke; Chih-Chieh Hsu; Ying-Chieh Tsai; Hsiu Mei Hsieh-Li
Journal:  BMC Complement Med Ther       Date:  2021-10-09

4.  Therapeutic Effects of a Novel Form of Biotin on Propionic Acid-Induced Autistic Features in Rats.

Authors:  Kazim Sahin; Cemal Orhan; Serdar Karatoprak; Mehmet Tuzcu; Patrick Brice Defo Deeh; Ibrahim Hanifi Ozercan; Nurhan Sahin; Merve Yilmaz Bozoglan; Sarah Sylla; Sara Perez Ojalvo; James R Komorowski
Journal:  Nutrients       Date:  2022-03-17       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.